Press Releases

TransCelerate BioPharma Inc., today announced that Janice Chang, currently its Chief Operating Officer, has been appointed as TransCelerate’s new Chief Executive Officer. Janice will assume the role on January 1, 2023. Read more in the press release.

Explore

September 9, 2021

TransCelerate BioPharma Commences Collaborative Development of a Novel Digital Data Flow Solution for Study Start-Up

TransCelerate BioPharma Inc. (TransCelerate) announced today that it has commenced development on a reference implementation of a study definitions repository. The study definitions repository is a novel central component aimed at facilitating the exchange of structured study definitions across clinical systems using technical and data standards. For the full press release, please click here.

Explore

June 7, 2021

BioCelerate Continues to Help Improve Nonclinical Study Operations through Public Private Partnership with the FDA

BioCelerate, a subsidiary of TransCelerate BioPharma Inc. that focuses on identifying and developing pragmatic and tangible solutions to improve efficiencies in nonclinical research, today announced that it has released the first set of its solutions as part of its Public Private Partnership (PPP) with the U.S. Food & Drug Administration’s Center for Drug Evaluation and…

Explore